Liede et al. [22] identified 42 sequence variants harboring 31 BRCA1 mutations and 11 BRCA2 variants in their study group of 341 women with breast cancer and 120 women with ovarian cancer. This evidence concerns the gene BRCA2 and ovarian carcinoma.